Benoquin

   
Google
 
Web NewDrugInformation.com

Benoquin


Drug - Benoquin
The trade name of the product as shown on the labeling.

Dosage - CREAM; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Monobenzone
Multiple ingredients are in alphabetical order.

Strength - 20%
The potency of the active ingredient(s), Monobenzone. May repeat for multiple part products.

Applicant - VALEANT PHARM INTL
The firm name holding legal responsibility for Benoquin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 008173
The FDA assigned number to Benoquin. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Benoquin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Benoquin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Benoquin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Benoquin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Valeant Pharmaceuticals International
The full name of the firm holding legal responsibility for the new application of Benoquin.

Benoquin